Allergen Alert

Test your plate, eat safe.

Lyon, France · Founded 2023 · $3.6M raised

Headquarters
Lyon
Employees
1–10
Founded
2023
Business Model
B2C
Total Funding
$3.6M
Last Round
$3.6M SeedOct 2025
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Allergen Alert is a French deeptech startup and spin-off of bioMérieux, a global leader in in-vitro diagnostics and food safety. The company is developing a portable, pocket-sized mini lab device that enables individuals and food service professionals to detect food allergens and gluten in meals quickly and reliably — with results in minutes. The device automates and miniaturizes professional laboratory allergen-detection methods, requiring no scientific expertise from the user. Allergen Alert was founded after CEO Bénédicte Astier's daughter suffered an anaphylactic shock, inspiring a mission to make eating safer for the 550 million people worldwide living with food allergies. The company targets consumers with severe food allergies, celiac disease, as well as restaurants, hotels, schools, hospitals, and travel operators. Allergen Alert won the Best Startup award at CES 2026 and was selected among the top 100 startups to invest in 2026 by Challenges magazine. The device detects the nine major allergens responsible for 80% of allergic reactions, including peanuts, tree nuts, milk, eggs, fish, shellfish, wheat, soy, and sesame. Pre-orders are expected from late 2026, with the company targeting the US market as a future expansion.

Summary

Allergen Alert is a Biotech company based in Lyon, France, founded in 2023. It has raised $3.6M in total across 1 round, most recently a $3.6M Seed round in Oct 2025. Investors include Agrinnovation (Demeter) and bioMérieux.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundOct 2025
$3.6M

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Allergen Alert on Indexed.vc
<a href="https://indexed.vc/companies/allergen-alert"><img src="https://indexed.vc/api/badge/company/allergen-alert" alt="Allergen Alert on Indexed.vc" width="260" height="76" /></a>